Disclosure 0001214659-26-011596-2

SEC FORM 4

$45,675.00

Aquestive Therapeutics, Inc. (AQST)

Sale of 8,750 shares at $5.22 per share.

Reporting Person Korczynski Sherry · Officer Title Chief Commercial Officer · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001214659-26-011596 · filed 2026-09-11 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Aquestive Therapeutics, Inc. (AQST)." Disclosed 2026-09-11. https://desqlong.com/cards/0001214659-26-011596-2 (retrieved 2026-09-26).